CSE/CPTR (CSE/CPTR)

Canadian Securities Exchange: CSE/CPTR · CAD

CA$0.40

+0.13 (+48.1%)· Recorded snapshot

Market cap	1.4M
Revenue (ttm)	-5M
Net income (ttm)	-5.6M
EPS (ttm)	-CA$1.62
Shares out	3.5M
Volume	600
Beta	0.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): -5M
Net income (ttm): -5.6M
EPS (ttm): -CA$1.62
Market cap: 1.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-50.8

P25 n/aP50 n/aP75 n/a

ROIC-624.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/CPTR indicators

Market & fundamental data

Available fields

152

Groups with data

Currency

CAD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees	78
Employees change	0
Employees growth	0%
Enterprise value	CAD -5.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	2003
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA14075H3018
Last earnings date	2026-02-27
Last refreshed	2026-10-29
Last stock split date	2024-07-11
Last stock split type	Reverse
Market cap	CAD 1.4M
Next earnings date	2026-11-27
Price	CAD 0.40
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	cse/CPTR
Website	https://captorcapital.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-404.27%
FCF / EV yield	15.92%
FCF yield	-67.6%
Industry forward P/E	34.4x
P/B ratio	0.17x
Price / tangible book value	0.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	117.64%
Pretax margin	111.72%
Profit per employee	CAD -72,290
Profitable years	1
Revenue per employee	CAD -64,706
ROA	-30.09%
ROA (5Y)	-12.19%
ROCE	-71.78%
ROE	-50.84%
ROE (5Y)	-41.97%
ROIC	-624.67%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Net income growth years	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -5.9M
EPS	CAD -1.62
FCF per share	CAD -0.27
Free cash flow	CAD -942,840
Gross profit	CAD -5M
Net cash flow	CAD -942,840
Net income	CAD -5.6M
Operating income	CAD -5.9M
Revenue	CAD -5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-21.39
Book value per share	CAD 2.37
Debt / equity	0.08
Interest coverage	-15.18
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD 7.3M
Net cash / market cap	524.48%
Net cash growth	-42.89%
Net debt / equity	-0.88
Piotroski F-Score	1
Shareholders' equity	CAD 8.3M
Tangible book value	CAD 8.3M
Tangible book value per share	CAD 2.37
Total assets	CAD 9.7M
Total cash	CAD 8M
Total debt	CAD 681,014
Total liabilities	CAD 1.4M
WACC	20.19%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 9.7M
Current liabilities	CAD 1.4M
Current ratio	6.95
Net working capital	CAD 956,375
Quick ratio	6.95
Working capital	CAD 8.3M
Working capital turnover	-0.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.1%
Shareholder yield	0.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.75
1D price change	48.15%
1M price change	-31.03%
1M total return	-31.03%
1W price change	29.03%
1W total return	29.03%
1Y price change	21.21%
1Y return CAGR	21.23%
1Y total return	21.21%
20-day SMA	CAD 0.51
200-day SMA	CAD 0.94
3M price change	81.82%
3M total return	81.82%
3Y price change	-76.81%
3Y return CAGR	-38.56%
3Y total return	-76.81%
50-day SMA	CAD 0.38
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.70
52-week high date	2026-09-22
52-week low	CAD 0.20
52-week low date	2026-08-28
5Y price change	-97.68%
5Y return CAGR	-52.9%
5Y total return	-97.68%
6M price change	73.91%
6M total return	73.91%
All-time high	CAD 267.00
All-time high date	2018-01-25
All-time low	CAD 0.20
All-time low date	2026-08-28
Average true range (ATR)	CAD 0.09
Average volume	9.1K
Beta (1Y)	-0.64
Beta (2Y)	-0.42
Beta (5Y)	0.66
Change from 52-week high	-42.86%
Change from 52-week low	100%
Change from all-time high	-99.85%
Change from all-time low	100%
Change from open	0%
Day's gap	48.15%
Dollar volume	CAD 240
High price	CAD 0.40
Low price	CAD 0.40
Monthly RSI	41.29
Open price	CAD 0.40
Previous close	CAD 0.27
Price vs 150-day SMA	-46.43%
Price vs 20-day SMA	-22.03%
Price vs 200-day SMA	-57.34%
Price vs 50-day SMA	4.82%
Relative volume	0.07
RSI	47.52
Sharpe ratio	0.83
Sharpe ratio (3Y)	0.73
Sortino ratio	1.79
Sortino ratio (3Y)	1.54
Volume	600
Weekly RSI	38.23
YTD price change	66.67%
YTD total return	66.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares change (YoY)	-0.1%
Shares outstanding	3.5M

Deeper analysis on CSE/CPTR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/CPTR report

Is a complete CSE/CPTR research report available?

No complete published report is available for cse/CPTR (CSE/CPTR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/CPTR (CSE/CPTR)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/CPTR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/CPTR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/CPTR

Frequently asked questions